Ex Parte Luft - Page 6

                  Appeal 2007-2439                                                                                         
                  Application 10/089,668                                                                                   

                  CLAIM 28                                                                                                 
                         Appellant argues that nozzle spring 12 of Boecking is supported on a                              
                  non-injection end of control chamber 15 whereas claim 28 recites that the                                
                  restoring spring is supported on an injection end of the sleeve (Br. 4).                                 
                         We have considered Appellant’s argument and find it unpersuasive                                  
                  for the reasons below.                                                                                   
                         The Examiner takes the position that Appellant has failed to indicate                             
                  which end is the injection end and thus, “the broadest reasonable                                        
                  interpretation of ‘injection end’” can include any “end” which is associated                             
                  with “an injection” (Answer 7).  The Examiner uses this construction of the                              
                  claim term “an injection end” to determine that, since fuel is throttled into                            
                  control chamber 15 via inlet throttle 19, the end-face 13 of nozzle needle 5                             
                  which abuts the nozzle spring 12 must be “an injection end” (Answer 7).                                  
                  We agree.                                                                                                
                         As noted above, claims are given their broadest reasonable                                        
                  interpretation consistent with the Specification during examination.                                     
                  American Academy of Science, 367 F.3d at 1364, 70 USPQ2d at 1830.  An                                    
                  applicant “may demonstrate an intent to deviate from the ordinary and                                    
                  accustomed meaning of a claim term by including in the specification                                     
                  expressions of manifest exclusion or restriction, representing a clear                                   
                  disavowal of claim scope.”  American Academy of Science, 367 F.3d at                                     
                  1365, 70 USPQ2d at 1831.                                                                                 
                         Appellant has not included in his Specification “expressions of                                   
                  manifest exclusion or restriction” that would lead us to conclude that “an                               
                  injection end” has a different meaning than the ordinary and accustomed                                  
                  meaning given to it by the Examiner.  We determine that the Examiner                                     

                                                            6                                                              

Page:  Previous  1  2  3  4  5  6  7  8  9  Next

Last modified: September 9, 2013